OZEMPIC INJ. (SEMAGLUTIDE) is a once-weekly injectable prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It can be used with other diabetes medicines to help reduce A1C, a measure of average blood sugar levels over 2 to 3 months. OZEMPIC INJ. (SEMAGLUTIDE) is also approved to reduce the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with type 2 diabetes and established cardiovascular disease. Get your prescription for OZEMPIC INJ. (SEMAGLUTIDE) today and take the first step towards better blood sugar control.